Skip to main content
Clinical Trials/CTRI/2025/08/092617
CTRI/2025/08/092617
Not yet recruiting
Not Applicable

Efficacy of the Erector Spinae Plane Block (ESPB) versus Fentanyl for alleviating pain in patients with acute severe backache in the Emergency Department: a comparative parallel-group two-arm open label pilot randomized control trial

All India Institute of Medical Sciences, New Delhi1 site in 1 country60 target enrollmentStarted: September 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
All India Institute of Medical Sciences, New Delhi
Enrollment
60
Locations
1
Primary Endpoint
To assess the efficacy of successful pain relief after six hours of intervention in both ESPB arm and Fentanyl arm

Overview

Brief Summary

This study is designed as a comparative parallel group, two arm, open label, pilot randomized control trial to evaluate the efficacy of the Erector Spinae Plane Block versus Fentanyl in managing acute severe backache in patients presenting to the Emergency Department. Eligible participants include individuals aged 18 years or older who present with acute severe lumbar back pain, whether due to mechanical causes, malignancy related pain or trauma after excluding vertebral fractures. Each patient will undergo a thorough history taking and clinical examination. Those who are hemodynamically stable, have no known allergies to the study drugs and score of 7 or more on Defence and Veteran Pain Rating Scale will be enrolled, provided they meet all the inclusion criteria and no exclusion criteria apply. Randomization will be conducted using preformed, computer generated sequences employing a mixed block randomization method. To maintain allocation concealment, the generated sequences will be sealed in opaque envelopes. The primary objective is to evaluate the effectiveness of pain relief achieved six hours post intervention in both the ESPB and Fentanyl arms. The secondary objectives include assessing the safety profile, patient satisfaction and the quantity of rescue analgesic medications required within six hours post intervention, comparing outcomes between the intervention and control groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age 18 years or older
  • Acute severe lumbar back pain
  • DVPRS score of 7 or more.

Exclusion Criteria

  • Symptoms of cauda equina syndrome
  • Progressive neurologic symptoms
  • Abdominal Aorta Aneurysm
  • Vertebral fracture
  • Evidence of skin/soft tissue infection at the block site
  • Spine deformity (both acquired or congenital)
  • Known Bleeding Disorder
  • Unwillingness to participate
  • Pregnancy
  • Patients of Chronic liver disease, Chronic kidney Disease, Congestive heart failure

Outcomes

Primary Outcomes

To assess the efficacy of successful pain relief after six hours of intervention in both ESPB arm and Fentanyl arm

Time Frame: 30 minutes, 1 hour, 2 hours, 6 hours

Secondary Outcomes

  • To assess the amount of rescue analgesic medications required at 6 hours of intervention(6 hours)
  • To study safety of ESPB in comparison to Fentanyl at 6 hours(6 hours)
  • To evaluate patient satisfaction among patient groups receiving ESPB versus Fentanyl in terms of reduction of pain in Likert scale (from 0: ‘‘Very unsatisfied¨ to 5: ‘‘very satisfied¨)(6 hours)

Investigators

Sponsor
All India Institute of Medical Sciences, New Delhi
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Abhisek Nayak

All India Institute of Medical Sciences, New Delhi

Study Sites (1)

Loading locations...

Similar Trials